Phase I/II Study of Velcade®-Beam (V-Beam) and Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Relapsed Indolent Non-Hodgkin'S Lymphoma (NHL), Transformed or Mantle Cell Lymphoma (MCL)